How We WorkOrder NowSupport Privacy

Eye Catching Penny Movers – Dussault Apparel Inc, Generex Biotechnology Corporation, RXi Pharmaceuticals Corp, Kraig Biocraft Laboratories Inc

on 20/03/2013

Massapequa Park – March 20, 2013 — (Net PR News) -King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today, we bring a special trend analysis of the following stocks: Dussault Apparel Inc.(PINK:DUSS), Generex Biotechnology Corporation(PINK:GNBT), RXi Pharmaceuticals Corp(PINK:RXII), Kraig Biocraft Laboratories Inc(PINK:KBLB)

PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy

Dussault Apparel Inc. (PINK:DUSS) stock moved up 20.00% and finished the day at $0.0006. The day started out with a lower opening price of $0.0006, versus its prior close of $0.0005.

The company traded with the total volume of 2.78 million shares, while its average trading volume remained 4.44 million shares. The beta of DUSS stands at -7.00.

Have a look at the company’s graph: During the last 5 trades, the stock plummeted almost -14.29%. During the last one month it slipped with the percentage of -14.29%. Its year to date performance remained progressive 20%.

What was the Moving Force behind DUSS’ Bullish Run? Read This Research Report on DUSS

Dussault Apparel Inc. engages in the licensing of its Deuce collection of apparel in Canada and the United States. The company designs apparel, such as hats and T-shirts, hoodies and headwear and skateboards and swimwear for promotional events. It also sells limited edition prints of artwork through its Website.

Generex Biotechnology Corporation (PINK:GNBT) percentage change mounted 2.07% to close at $0.0296 with the total traded volume of 2.77 million shares, less than average volume of 3.66 million.

The Company’s year to date performance remained optimistic with the rise of 18.4%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -57.71%. Its beta value stands at 1.80 times and earnings per share was $-0.03. The company has a total of 372.06 million outstanding shares and its total market capitalization is $11.01 million.

For How Long will GNBT Fight for Profitability? Read This Trend Analysis report

The 52-week price range of the stock remained $0.0205- $0.1438, while during last trade its minimum price was $0.0283 and it gained its highest price of $0.0307. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.

RXi Pharmaceuticals Corp (PINK:RXII) started its trading session with the price of $0.335 and closed at $0.295 by scoring -10.61%.

A review of its graph: Previous 5 days graph demonstrated a positive move of +7.27%. RXII’s quarterly performance remained in the green with the percentage of +268.75%, while its year to date performance showed that the stock advanced overall 293.33%. The 52-week price range of the stock remained $0.03- $0.358, while during last trade its minimum price was $0.2529 and it gained its highest price of $0.358.

Why Should Investors Buy RXII After the Recent Fall? Just Go Here and Find Out

RXII’s stocks traded with total volume of 2.76 million shares, while the average trading volume remained 1.67 million shares. RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform.

Kraig Biocraft Laboratories Inc (PINK:KBLB), during the previous trading session, the stock showed a positive movement of +15.58%.

Graph values of the stock demonstrate these trends: Year to date performance of the stock remained positive with the rise of +137.33%. KBLB traded with volume of 2.75 million shares, while its average trading volume remained 886,366.00 shares.

Currently, the company has a market capitalization of $53.51 billion. Stock’s closing price was $0.089, while it started its day-trade at $0.08. Its 52-week price range was $0.305 – $0.097. Kraig Biocraft Laboratories, Inc., a development stage company, focuses on developing protein-based fibers using recombinant DNA technology for commercial applications in textile, specialty fiber, and technical textile industries.

For How Long will KBLB’s Gloss Attract Investors? Find out via this report

 

About Us:

King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.

King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.

Disclaimer:

Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.

An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.

Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/

Source: kingPennyStocks.com Posted Wed, March 20, 2013 14:19 - Permalink